PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,716 | -95.8% | 6,803 | -94.5% | 0.00% | -95.8% |
| Q2 2023 | $4,983,987 | -38.2% | 124,382 | +8.0% | 0.05% | -11.1% |
| Q1 2021 | $8,071,000 | -14.1% | 115,157 | -26.7% | 0.05% | -30.8% |
| Q4 2020 | $9,400,000 | +1.9% | 157,090 | +2.4% | 0.08% | -22.0% |
| Q3 2020 | $9,225,000 | +6.4% | 153,443 | -7.2% | 0.10% | +4.2% |
| Q2 2020 | $8,673,000 | +29806.9% | 165,300 | +18813.0% | 0.10% | – |
| Q1 2020 | $29,000 | -21.6% | 874 | +7.1% | 0.00% | – |
| Q4 2019 | $37,000 | -7.5% | 816 | -23.0% | 0.00% | – |
| Q3 2019 | $40,000 | – | 1,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |